Peptides for Anti-Aging Skin Research

Anti-aging skin research focuses on peptides that stimulate collagen synthesis, restore ECM integrity, and modulate skin cell turnover. GHK-cu is studied for collagen I/III upregulation and wound healing. Epitalon is investigated for telomerase activity and cellular senescence. TB-500 is examined for inflammatory resolution and tissue remodelling in aging skin contexts.

GHK-cu in vitro and ex vivo human skin studies show significant collagen induction and growth factor upregulation. Epitalon research suggests telomerase upregulation in cultured cells, though human skin-aging applications remain preliminary. TB-500 studies document reduced inflammatory cytokines and enhanced collagen remodelling.

Human clinical trials on peptide-based skin aging are sparse; most data come from cell cultures or animal models. Long-term safety and efficacy in anti-aging contexts are underexplored. Comparative effectiveness against established skincare ingredients (retinol, vitamin C) lacks rigorous data. Publication bias toward positive results is evident.

Anti-aging peptides are not ARTG-listed for cosmetic use. Research-grade peptides for skin research can be legally obtained from compliant suppliers; personal cosmetic application is not a TGA-approved pathway. Cosmetic claims require specific therapeutic goods registration or exemption status.